Journal article
Heparin therapy during pregnancy. Risks to the fetus and mother.
Abstract
The true maternal and fetal risks of heparin therapy during pregnancy are unknown, because most published studies are small and do not report consecutively treated patients. In order to address these issues, we performed a retrospective cohort study of 100 pregnancies in 77 women treated with heparin during pregnancy. In 98 pregnancies heparin therapy was given for the prevention or treatment of venous thromboembolism; in the remaining 2, …
Authors
Ginsberg JS; Kowalchuk G; Hirsh J; Brill-Edwards P; Burrows R
Journal
JAMA Internal Medicine, Vol. 149, No. 10, pp. 2233–2236
Publisher
American Medical Association (AMA)
Publication Date
October 1, 1989
DOI
10.1001/archinte.149.10.2233
ISSN
2168-6106